Showing results (101-110 of 569) with videos related to

Sort By:
Pageof 57
Cancer Treatment Reports|August 1, 1979
Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumorsJ Z Finklestein, G Higgins, W Krivit, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 19, 2008
Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospitalT Stoeva, P G Higgins, K Bojkova, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2004
Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumanniiPaul G Higgins, Hilmar Wisplinghoff, Danuta Stefanik, et al.
BMC Bioinformatics|July 29, 2006
Comparison and evaluation of methods for generating differentially expressed gene lists from microarray dataIan B Jeffery, Desmond G Higgins, Aedín C Culhane
International Journal of Antimicrobial Agents|November 1, 2019
In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumanniiHarald Seifert, Danuta Stefanik, Melanie Olesky, et al.
Water Research|May 4, 2018
Characterization of Acinetobacter baumannii from water and sludge line of secondary wastewater treatment plantPaul G Higgins, Jasna Hrenovic, Harald Seifert, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 14, 2007
A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TUP G Higgins, H Wisplinghoff, O Krut, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
The Asp20-to-Asn Substitution in the Response Regulator AdeR Leads to Enhanced Efflux Activity of AdeB in Acinetobacter baumanniiJennifer Nowak, Thamarai Schneiders, Harald Seifert, et al.
Journal of Clinical Microbiology|October 1, 2010
gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3Paul G Higgins, Marlene Lehmann, Hilmar Wisplinghoff, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strainsPaul G Higgins, Hilmar Wisplinghoff, Danuta Stefanik, et al.
Pageof 57